Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases.

Journal of proteome research - 4 Oct 2024

Wong Geoffrey Yuet Mun, Li Jun, McKay Matthew, Castaneda Miguel, Bhimani Nazim, Diakos Connie, Hugh Thomas J, Molloy Mark P

Abstract excerpt

Clinical and pathological factors are insufficient to accurately identify patients at risk of early recurrence after curative-intent treatment of colorectal liver metastases (CRLM). This study aimed to identify candidate prognostic proteogenomic biomarkers for early intrahepatic recurrence after curative-intent resection of CRLM. Patients diagnosed with intrahepatic recurrence within 6 months of liver resection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Liver Neoplasms

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Proteogenomics

Source

Identifiers

PMID: 39264718
DOI: 10.1021/acs.jproteome.4c00440

Genes

SMAD4
APC
KRAS
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases.PMID 39264718Read ↗

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stages I-III colorectal cancerSemantic proximity Read ↗

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerSemantic proximity Read ↗

Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancerSemantic proximity Read ↗

Predicting recurrence in patients with node-negative perihilar cholangiocarcinoma after an R0 resection.Semantic proximity Read ↗

Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.Semantic proximity Read ↗

Proteomic Profiling and Biomarker Discovery in Colorectal Liver MetastasesSemantic proximity Read ↗

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.Semantic proximity Read ↗

BRAF Mutation Drives Early Multifocal Intrahepatic Recurrence after Curative Resection of Liver-Limited Colorectal Metastases.Semantic proximity Read ↗

Molecular prediction of early recurrence after resection of hepatocellular carcinoma.Semantic proximity Read ↗

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Semantic proximity Read ↗

Gene Signature Is Associated with Early Stage Rectal Cancer RecurrenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.